EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Inhibition of transforming growth factor‐β signals suppresses tumor formation by regulation of tumor microenvironment networks

Shiori Tokizaki, Katarzyna A Podyma-Inoue iD, Takehisa Matsumoto, Kazuki Takahashi, Miho Kobayashi iD, Haruka Ibi, Shizuka Uchida, Sadahiro Iwabuchi, Hiroyuki Harada, Shinichi Hashimoto, Kohei Miyazono iD, Mikako Shirouzu und 1 weitere

Cancer Science · 2024

DOI: 10.1111/cas.16006 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Science, 2024. Verfasst von Shiori Tokizaki und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oral and Maxillofacial Surgical Oncology, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University (TMDU), T…. Hauptthemen laut MEDLINE: Protein Serine-Threonine Kinases, Mouth Neoplasms. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Japan Agency for Medical Research and Development, Japan Science and Technology Corporation SPRING, Japan Society for the Promotion of Science.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The tumor microenvironment (TME) consists of cancer cells surrounded by stromal components including tumor vessels. Transforming growth factor‐β (TGF‐β) promotes tumor progression by inducing epithelial–mesenchymal transition (EMT) in cancer cells and stimulating tumor angiogenesis in the tumor stroma. We previously developed an Fc chimeric TGF‐β receptor containing both TGF‐β type I (TβRI) and type II (TβRII) receptors (TβRI‐TβRII‐Fc), which trapped all TGF‐β isoforms and suppressed tumor growth. However, the precise mechanisms underlying this action have not yet been elucidated. In the present study, we showed that the recombinant TβRI‐TβRII‐Fc protein effectively suppressed in vitro EMT of oral cancer cells and in vivo tumor growth in a human oral cancer cell xenograft mouse model. Tumor cell proliferation and angiogenesis were suppressed in tumors treated with TβRI‐TβRII‐Fc. Molecular profiling of human cancer cells and mouse stroma revealed that K‐Ras signaling and angiogenesis were suppressed. Administration of TβRI‐TβRII‐Fc protein decreased the expression of heparin‐binding epidermal growth factor‐like growth factor (HB‐EGF), interleukin‐1β (IL‐1β) and epiregulin (EREG) in the TME of oral cancer tumor xenografts. HB‐EGF increased proliferation of human oral cancer cells and mouse endothelial cells by activating ERK1/2 phosphorylation. HB‐EGF also promoted oral cancer cell‐derived tumor formation by enhancing cancer cell proliferation and tumor angiogenesis. In addition, increased expressions of IL‐1β and EREG in oral cancer cells significantly enhanced tumor formation. These results suggest that TGF‐β signaling in the TME controls cancer cell proliferation and angiogenesis by activating HB‐EGF/IL‐1β/EREG pathways and that TβRI‐TβRII‐Fc protein is a promising tool for targeting the TME networks.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Protein Serine-Threonine KinasesMouth NeoplasmsHumansMiceAnimalsTransforming Growth Factor betaHeparin-binding EGF-like Growth FactorEndothelial CellsTumor MicroenvironmentReceptors, Transforming Growth Factor betaTransforming Growth Factor beta1Transforming Growth Factors

Stichwörter der Autor:innen

epithelial-mesenchymal transitionheparin-binding epidermal growth factor-like growth factorinterleukin-1betatransforming growth factor-betatumor microenvironment

Substanzen

Protein Serine-Threonine KinasesTransforming Growth Factor betaHeparin-binding EGF-like Growth FactorReceptors, Transforming Growth Factor betaTransforming Growth Factor beta1Transforming Growth Factors

Autor:innen und Institutionen

  • Department of Oral and Maxillofacial Surgical Oncology, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University (TMDU), Tokyo, Japan.
  • Department of Biochemistry, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University (TMDU), Tokyo, Japan.
  • RIKEN Center for Biosystems Dynamics Research, Yokohama, Japan.
  • Institute of Industrial Science, The University of Tokyo, Tokyo, Japan.
  • Center for RNA Medicine, Department of Clinical Medicine, Aalborg University, Copenhagen, Denmark.
  • Department of Molecular Pathophysiology, Wakayama Medical University, Wakayama, Japan.

ORCID-Profile: Katarzyna A Podyma-Inoue, Miho Kobayashi, Kohei Miyazono, Tetsuro Watabe

Förderung

  • Japan Agency for Medical Research and Development
  • Japan Science and Technology Corporation SPRING
  • Japan Society for the Promotion of Science

Zitieren

APA

Tokizaki, S., Podyma-Inoue, K. A., Matsumoto, T., Takahashi, K., Kobayashi, M., Ibi, H., Uchida, S., Iwabuchi, S., Harada, H., Hashimoto, S., Miyazono, K., Shirouzu, M., & Watabe, T. (2024). Inhibition of transforming growth factor‐β signals suppresses tumor formation by regulation of tumor microenvironment networks. Cancer Science. https://doi.org/10.1111/cas.16006

Vancouver

Tokizaki S, Podyma-Inoue KA, Matsumoto T, Takahashi K, Kobayashi M, Ibi H, et al. Inhibition of transforming growth factor‐β signals suppresses tumor formation by regulation of tumor microenvironment networks. Cancer Science. 2024. doi:10.1111/cas.16006

BibTeX
@article{Tokizaki2024,
  author = {Tokizaki, Shiori and Podyma-Inoue, Katarzyna A and Matsumoto, Takehisa and Takahashi, Kazuki and Kobayashi, Miho and Ibi, Haruka and Uchida, Shizuka and Iwabuchi, Sadahiro and Harada, Hiroyuki and Hashimoto, Shinichi and Miyazono, Kohei and Shirouzu, Mikako and Watabe, Tetsuro},
  title = {Inhibition of transforming growth factor‐β signals suppresses tumor formation by regulation of tumor microenvironment networks},
  journal = {Cancer Science},
  year = {2024},
  doi = {10.1111/cas.16006}
}
Kostenlos starten →